Company news

Certara, Inc. news in 2023

Certara, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

December 12, 2023

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

November 20, 2023

Certara Reports Third Quarter 2023 Financial Results

November 7, 2023

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

October 10, 2023

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

September 18, 2023

Certara Simcyp™ Group Awarded Two New Grants from US FDA

August 28, 2023

Certara Reports Second Quarter 2023 Financial Results

August 8, 2023

Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset

August 2, 2023

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

July 12, 2023

Certara Reports First Quarter 2023 Financial Results

May 7, 2023

Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year

April 26, 2023

Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference

April 9, 2023

Xentria Announces Peer Reviewed Publication of Biosimulation Model in Frontiers in Pharmacology Journal

March 20, 2023

A.I. Coming to Certara’s D360 Scientific Informatics Software

March 8, 2023

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

March 6, 2023

Certara Reports Fourth Quarter and Full Year 2022 Financial Results

February 28, 2023

Certara Announces Transition Plan for Chief Financial Officer

February 28, 2023

Certara to Participate in the Barclays Global Healthcare Conference

February 26, 2023

Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023

January 31, 2023

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation

January 3, 2023

Calls in 2023

Decks in 2023